Premium
Secretomic analysis of extracellular vesicles originating from polyomavirus‐negative and polyomavirus‐positive Merkel cell carcinoma cell lines
Author(s) -
Konstantinell Aelita,
Bruun JackAnsgar,
Olsen Randi,
Aspar Augusta,
ŠkalkoBasnet Nataša,
Sveinbjørnsson Baldur,
Moens Ugo
Publication year - 2016
Publication title -
proteomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.26
H-Index - 167
eISSN - 1615-9861
pISSN - 1615-9853
DOI - 10.1002/pmic.201600223
Subject(s) - microvesicles , merkel cell carcinoma , merkel cell polyomavirus , biology , exosome , cancer research , tetraspanin , cell culture , cell , virology , carcinoma , microrna , genetics , gene
Extracellular vesicles or exosomes constitute an evolutionarily conserved mechanism of intercellular signaling. Exosomes are gaining an increasing amount of attention due to their role in pathologies, including malignancy, their importance as prognostic and diagnostic markers, and their potential as a therapeutic tool. Merkel cell carcinoma (MCC) is an aggressive form of skin cancer with a poor prognosis. Because an effective systemic treatment for this cancer type is currently not available, an exosome‐based therapy was proposed. However, comprehensive secretome profiling has not been performed for MCC. To help unveil the putative contribution of exosomes in MCC, we studied the protein content of MCC‐derived exosomes. Since approximately 80% of all MCC cases contain Merkel cell polyomavirus (MCPyV), the secretomes of two MCPyV‐negative and two MCPyV‐positive MCC cell lines were compared. We identified with high confidence 164 exosome‐derived proteins common for all four cell lines that were annotated in ExoCarta and Vesiclepedia databases. These include proteins implicated in motility, metastasis and tumor progression, such as integrins and tetraspanins, intracellular signaling molecules, chaperones, proteasomal proteins, and translation factors. Additional virus‐negative and virus‐positive MCC cell lines should be examined to identify highly representative exosomal proteins that may provide reliable prognostic and diagnostic biomarkers, as well as targets for treatment in the future. Data are available via ProteomeXchange with identifier PXD004198.